Loriaux F, Jacqueson A, Rota M, Allard D
Laboratoire Central de Biochimie, Hôpital Boucicaut, Paris.
Ann Biol Clin (Paris). 1988;46(3):181-3.
We evaluated the performances of the Abbott fluorescence polarization assay (FPIA) utilizing the TDx system for human total triiodothyronine (T3) in hyperthyroidism. We compared the results with an immunoenzymometric assay (IEA) (Enzymum Test T3 Boehringer-Mannheim). Greatest attention was focused on the diagnosis of hyperthyroidism because detection of subclinical hyperthyroidism is important. The repeatability of the Abbott fluorescence polarization assay was satisfying (m = 8.07 +/- 0.37 nmol.l-1, CV = 4.59%). The reproducibility was tested with Abbott control sera: m = 4.58 +/- 0.53 nmol.l-1 and CV = 11.5 per cent for level M; m = 7.95 +/- 0.66 nmol.l-1 and CV = 8.23 per cent for level H; m = 2.38 +/- 0.39 nmol.l-1 and CV = 16.5 for level L. The correlation of results of the Abbott assay with those of the Boehringer assay was good for samples from hyperthyroid patients. Values for hyperthyroid and euthyroid subjects were resolved slightly better with the Abbott FPIA than with Boehringer IEA. The Abbott total T3 fluorescence polarization assay may have an additional role to play in monitoring thyroid function in patients under iodine treatment (amiodarone) to eliminate a secondary hyperthyroïdism.
我们评估了利用TDx系统的雅培荧光偏振免疫分析(FPIA)检测甲状腺功能亢进患者血清总三碘甲状腺原氨酸(T3)的性能。我们将结果与免疫酶联分析法(IEA)(Boehringer-Mannheim公司的Enzymum Test T3)进行了比较。由于亚临床甲状腺功能亢进的检测很重要,因此对甲状腺功能亢进的诊断给予了最大关注。雅培荧光偏振免疫分析的重复性令人满意(均值m = 8.07 +/- 0.37 nmol·l-1,变异系数CV = 4.59%)。使用雅培对照血清测试了重现性:M水平时,均值m = 4.58 +/- 0.53 nmol·l-1,CV = 11.5%;H水平时,均值m = 7.95 +/- 0.66 nmol·l-1,CV = 8.23%;L水平时,均值m = 2.38 +/- 0.39 nmol·l-1,CV = 16.5%。对于甲状腺功能亢进患者的样本,雅培分析法与Boehringer分析法的结果相关性良好。使用雅培FPIA对甲状腺功能亢进和甲状腺功能正常受试者数值的分辨略优于Boehringer IEA。雅培总T3荧光偏振免疫分析在监测接受碘治疗(胺碘酮)患者的甲状腺功能以排除继发性甲状腺功能亢进方面可能具有额外作用。